Related Experiment Video
Updated: Aug 17, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Overview of cancer epigenetics
1Department of Urology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA 90089-9181, USA. jones_p@ccnt.hsc.usc.edu
Abstract:
Epigenetic mechanisms including DNA and histone modifications result in silencing of genes without changing the coding sequence of the gene. Even though these events are heritable, they are potentially reversible, thus opening up opportunities for therapeutic intervention. The importance of epigenetic changes in human cancer is only now being recognized in the medical community. A series of discoveries over the last four decades has thrust epigenetics into the forefront of new drug discoveries. Three systems--DNA methylation, RNA-associated silencing, and histone modification--are used to initiate and sustain epigenetic silencing. Current knowledge suggests that agents that intervene in this process by "turning back on" silenced genes may represent a significant advancement in treating many forms of cancer. In addition, changed patterns of methylation can be detected with a high degree of sensitivity thus providing clinicians with prognostic information.
Insights
Epigenetic modifications silence genes reversibly, offering new cancer treatment avenues. Detecting methylation patterns also aids in cancer prognosis.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Epigenetic mechanisms, including DNA and histone modifications, regulate gene expression without altering DNA sequence.
- These heritable yet reversible epigenetic events are increasingly recognized for their role in human cancer development.
- Recent decades have seen epigenetics emerge as a critical area for novel cancer drug discovery.
Purpose of the Study:
- To highlight the significance of epigenetic mechanisms in cancer.
- To explore the therapeutic potential of reversing gene silencing in cancer treatment.
- To discuss the utility of epigenetic markers in cancer prognosis.
Main Methods:
- Review of established epigenetic systems: DNA methylation, RNA-associated silencing, and histone modification.
- Analysis of current research on epigenetic alterations in various cancer types.
- Examination of diagnostic and prognostic applications of epigenetic markers.
Main Results:
- Epigenetic silencing, driven by DNA methylation, RNA interference, and histone modifications, plays a crucial role in oncogenesis.
- Therapeutic strategies targeting the reversal of epigenetic silencing show promise for cancer treatment.
- Aberrant DNA methylation patterns are sensitive biomarkers for cancer detection and prognostication.
Conclusions:
- Targeting epigenetic modifications represents a promising frontier in oncology drug development.
- Reactivating silenced tumor suppressor genes via epigenetic intervention could offer novel therapeutic strategies.
- Epigenetic profiling, particularly DNA methylation analysis, provides valuable prognostic information for cancer patients.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

